<?xml version='1.0' encoding='utf-8'?><BODY>Pragma Bio-Tech Inc, a
clinical testing company, said it has started performing
comparative studies on differnet varieties of nitroglycerin for
use in the treatment of angina pectoris episodes.
    The company would not disclose details of the testing.
 Reuter
    </BODY>